These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29672896)

  • 1. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.
    Terrault NA
    Hepatology; 2018 Nov; 68(5):2035-2038. PubMed ID: 29672896
    [No Abstract]   [Full Text] [Related]  

  • 2. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
    Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
    Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
    Jadoul M; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Gordon CE; Earley A; Di M; Martin P
    Kidney Int; 2018 Oct; 94(4):663-673. PubMed ID: 30243313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in end stage renal disease and after kidney transplant.
    Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 6. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs).
    La Manna G
    J Nephrol; 2018 Apr; 31(2):185-187. PubMed ID: 29411309
    [No Abstract]   [Full Text] [Related]  

  • 7. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease.
    Gordon CE; Balk EM; Francis JM
    Semin Dial; 2019 Mar; 32(2):187-195. PubMed ID: 30496617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming a treatment barrier in treating hepatitis C in dialysis patients.
    Lapumnuaypol K; Feyssa E
    Semin Dial; 2018 Mar; 31(2):193. PubMed ID: 29405426
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.
    Ladino M; Roth D
    Nat Rev Nephrol; 2018 Jan; 14(1):6-8. PubMed ID: 29176656
    [No Abstract]   [Full Text] [Related]  

  • 10. An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease.
    Olson MR; Grewal KS; Bingaman A; Zaki R; Stewart S; Horton J; Araya V; Ortiz J
    Exp Clin Transplant; 2009 Dec; 7(4):203-13. PubMed ID: 20353368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis].
    Yang GL; Lei XZ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):233-236. PubMed ID: 28482415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis C virus infection in dialysis patients: does it need special attention?
    Rezaee-Zavareh MS; Ramezani-Binabaj M; Einollahi B
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):368-9. PubMed ID: 25758893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis C: in 2015, who should be screened first?].
    Nau JY
    Rev Med Suisse; 2015 Apr; 11(470):888-9. PubMed ID: 26050310
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for hepatitis C.
    Med Lett Drugs Ther; 2012 Oct; 54(1401):81-2. PubMed ID: 23059420
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy of hepatitis C virus infection: a brief review.
    Quan DJ
    Nephrol Nurs J; 2009; 36(3):333-7. PubMed ID: 19588704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is widespread screening for hepatitis C justified?
    Koretz RL; Lin KW; Ioannidis JP; Lenzer J
    BMJ; 2015 Jan; 350():g7809. PubMed ID: 25587052
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viral hepatitis in hemodialysis and renal transplantation patients].
    Pol S; Legendre C
    Nephrologie; 1994; 15(3):191-5. PubMed ID: 7969710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.